Loading...

Poseida Therapeutics ($PSTX)

Stock Image

PSTX Overview

Poseida Therapeutics, a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs.The company is developing a pipeline of solutions for the treatment of hematological malignancies and solid tumors, as well as vivo programs for liver-directed gene therapies for rare diseases.In addition, it offers CAR-T therapies for the treatment for cancer. Further, it offers gene therapies for rare and life-threatening diseases, including Ornithine transcarbamylase (OTC) deficiency and methylmalonic acidemia (MMA), and genetic liver diseases.The company was founded in 2014 and is headquartered in San Diego, California. (From: StockAnalysis.com)

MORE ABOUT Poseida Therapeutics

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.